https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04576091-2026-07-29 Hipa.ai en 2026-07-29T00:00:00.000Z Pembrolizumab Combination for Recurrent Head & Neck Cancer: Phase 1 MTD of 10 mg https://hipa.ai/drug/canagliflozin/updates/boxed-warning-revised-metformin-hydrochloride-label-2026-07-28 Hipa.ai en 2026-07-28T00:00:00.000Z Metformin Hydrochloride Boxed Warning Revised for Lactic Acidosis Risk https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-07-28 Hipa.ai en 2026-07-28T00:00:00.000Z Metformin Hydrochloride Label Revised with Boxed Warning for Lactic Acidosis https://hipa.ai/drug/tofacitinib/updates/boxed-warning-revised-tofacitinib-label-effective-2026-07-27-2026-07-27 Hipa.ai en 2026-07-27T00:00:00.000Z Tofacitinib Boxed Warning Revised to Include Mortality, MACE, and Thrombosis https://hipa.ai/drug/liraglutide/updates/boxed-warning-revised-liraglutide-label-effective-2026-07-27-2026-07-27 Hipa.ai en 2026-07-27T00:00:00.000Z Liraglutide Boxed Warning Revised for Thyroid C-Cell Tumor Risk